Cargando…
The state of the art of adeno-associated virus-based vectors in gene therapy
The adeno-associated virus (AAV) has rapidly gained popularity in gene therapy since the establishment of the first AAV2 infectious clone, in 1982, due to some of their distinguishing characteristics such as lack of pathogenicity, wide range of infectivity, and ability to establish long-term transge...
Autores principales: | Coura, Renata dos Santos, Nardi, Nance Beyer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2104528/ https://www.ncbi.nlm.nih.gov/pubmed/17939872 http://dx.doi.org/10.1186/1743-422X-4-99 |
Ejemplares similares
-
Correction: The state of the art of adeno-associated virus-based vectors in gene therapy
por: dos Santos Coura, Renata, et al.
Publicado: (2010) -
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017) -
Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023) -
Novel Cytotoxic Vectors Based on Adeno-Associated Virus
por: Kohlschütter, Johannes, et al.
Publicado: (2010) -
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)